Différences

Ci-dessous, les différences entre deux révisions de la page.

--- aha_2025 [2025/11/09 17:24] – clementbecle
+++ aha_2025 [2025/11/09 19:39] (Version actuelle) – clementbecle
@@ Ligne 1: / Ligne 1: @@
 ====== AHA 2025 ======
-  * [[lb.01|LBS.01 Essais thérapeutiques cardiométaboliques]] : DR10624, CTX310, Olezarsen, Vesalius-CV
+  * [[lb.01|LBS.01 Groundbreaking Trials in Cardiometabolic Therapeutics]] : DR10624, CTX310, Olezarsen, Vesalius-CV
-  * [[LBS.02]] Antithrombotic agent in AF
+  * [[LBS.02|LBS.02 Dilemmas in antithrombotic therapy in AF care post procedures]] : Adapt-AF, Optima-AF, Closure-AF et Ocean trial.
-  * [[LBS.03]] Breaking sciences in Valvulopathie et coronaropathies
+  * [[LBS.03|LBS.03 Cutting Edge Valve and Coronary Trials]] : Recovery, Ablation trial, Favor-IV QVAS et Top trial.
-  * [[LBS.04]]
+  * [[LBS.04|LBS.04 Cardiometabolic and Lifestyle Interventions for AF]] : Dare-AF, Meta-AF et DECAF.
-  * [[LBS.05]]
+  * [[LBS.05|LBS.05 Practice Changing Trials in Blood Pressure Control ]]
-  * [[LBS.06]]
+  * [[LBS.06|LBS.06 Approaches to Ischemic Heart Disease Before During and After Hospitalization]]
-  * [[LBS.07]]
+  * [[LBS.07|LBS.07 Recipes for Success in Heart Failure]] : Poly-HF, Caviar, Food-HF, Surpass-CVOT